Isomer separation and gas-phase configurations of organoruthenium anticancer complexes: ion mobility mass spectrometry and modeling.
about
Chemical structure identification in metabolomics: computational modeling of experimental featuresReview on ion mobility spectrometry. Part 1: current instrumentation.Collision cross-section determination and tandem mass spectrometric analysis of isomeric carotenoids using electrospray ion mobility time-of-flight mass spectrometry.Localization of fatty acyl and double bond positions in phosphatidylcholines using a dual stage CID fragmentation coupled with ion mobility mass spectrometry.MolFind: a software package enabling HPLC/MS-based identification of unknown chemical structures.Ion Mobility-Mass Correlation Trend Line Separation of Glycoprotein Digests without DeglycosylationApproaches for the rapid identification of drug metabolites in early clinical studies.Recent advances in metabolite identification and quantitative bioanalysis by LC-Q-TOF MS.Ion mobility spectrometry-mass spectrometry (IMS-MS) of small molecules: separating and assigning structures to ions.Metabolomics and lipidomics using traveling-wave ion mobility mass spectrometry.Integrating ion mobility spectrometry into mass spectrometry-based exposome measurements: what can it add and how far can it go?Investigation of isomeric flavanol structures in black tea thearubigins using ultraperformance liquid chromatography coupled to hybrid quadrupole/ion mobility/time of flight mass spectrometry.Combining density functional theory (DFT) and collision cross-section (CCS) calculations to analyze the gas-phase behaviour of small molecules and their protonation site isomers.A combined IM-MS/DFT study on [Pd(MPAA)]-catalyzed enantioselective C-H activation: relay of chirality through a rigid framework.Structural analysis of ruthenium-arene complexes using ion mobility mass spectrometry, collision-induced dissociation, and DFT.Mass spectrometric strategies to improve the identification of Pt(II)-modification sites on peptides and proteins.Characterizing the lipid and metabolite changes associated with placental function and pregnancy complications using ion mobility spectrometry-mass spectrometry and mass spectrometry imaging.Polymers for Traveling Wave Ion Mobility Spectrometry Calibration.Designing organometallic compounds for catalysis and therapy.Differentiation of prototropic ions in regioisomeric caffeoyl quinic acids by electrospray ion mobility mass spectrometry.Comprehensive analysis of fatty alcohol ethoxylates by ultra high pressure hydrophilic interaction chromatography coupled with ion mobility spectrometry mass spectrometry using a custom-designed sub-2 μm column.Structural Characterization of Anticancer Drug Paclitaxel and Its Metabolites Using Ion Mobility Mass Spectrometry and Tandem Mass Spectrometry.Determination of testosterone and epitestosterone glucuronides in urine by ultra performance liquid chromatography-ion mobility-mass spectrometry
P2860
Q26851316-D5539857-A1D9-4972-B76A-86E4523531E7Q34451523-966D3D62-8DC7-4805-ACFF-FE8200CEDF72Q34560979-3D8CBDE2-CA28-41AA-9365-75834E8B0BC6Q35172824-E9DA75D1-D4F0-4B82-8E0B-E0038B161CBFQ36469246-39A22665-2B13-4759-A02B-0C71D3E665B9Q37057130-1708C5E7-FD42-499F-9137-3609A5E9EEE0Q37830698-95490EA1-2A96-43CE-AD1B-CB2F6E6C66C4Q38005438-4C19A2A4-6FE8-4796-97C4-D3348B414E95Q38040005-B9899EDB-B855-4EFA-8581-5E0C5ABAE190Q38903248-AA1918A6-1460-4127-A9CB-DD89F3985F51Q39030354-0099BC48-6CD4-40D0-B9D5-69D5D1C504F9Q39098283-FC6AF0B6-F2F7-426F-B33E-F056F2928304Q39708148-7CC744B6-E25F-4ABD-A584-BDEB059782F9Q43677903-BDD2AB0E-F573-4073-814B-1E9F5C24B767Q46595407-9396FD76-4DEB-4D64-9ED8-B7C0A6D09645Q46892086-EDCD4217-A43D-4D8C-BE68-EC4E1E5E5219Q47136387-E2E31A45-1CE7-46F9-B57F-1E99C1E0C4E7Q48005783-258BAC07-6876-4D01-AE3D-70895F7C7903Q48007506-5C7328FF-B59E-4012-9A43-5F9073E85D3BQ51833664-EF41943A-FA1F-4071-B953-3B84D5B2AB4BQ53270211-C8BAE3CD-243E-421C-82AD-4DF9139170CEQ53813485-AB380CA7-4522-4564-89E9-9B63B1839264Q58213120-6D31BB1B-4523-42CA-A4C1-52D66948C49F
P2860
Isomer separation and gas-phase configurations of organoruthenium anticancer complexes: ion mobility mass spectrometry and modeling.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Isomer separation and gas-phas ...... ass spectrometry and modeling.
@en
Isomer separation and gas-phas ...... ass spectrometry and modeling.
@nl
type
label
Isomer separation and gas-phas ...... ass spectrometry and modeling.
@en
Isomer separation and gas-phas ...... ass spectrometry and modeling.
@nl
prefLabel
Isomer separation and gas-phas ...... ass spectrometry and modeling.
@en
Isomer separation and gas-phas ...... ass spectrometry and modeling.
@nl
P2093
P2860
P1476
Isomer separation and gas-phas ...... ass spectrometry and modeling.
@en
P2093
Iain Campuzano
Jonathan P Williams
Kevin Giles
P Mark Rodger
Peter J Sadler
Tijana Bugarcic
P2860
P2888
P304
P356
10.1016/J.JASMS.2009.02.016
P577
2009-02-14T00:00:00Z
P5875
P6179
1028732982